Wanjun Lin

519 total citations
28 papers, 375 citations indexed

About

Wanjun Lin is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Wanjun Lin has authored 28 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Pharmacology. Recurrent topics in Wanjun Lin's work include Berberine and alkaloids research (3 papers), Epigenetics and DNA Methylation (3 papers) and interferon and immune responses (2 papers). Wanjun Lin is often cited by papers focused on Berberine and alkaloids research (3 papers), Epigenetics and DNA Methylation (3 papers) and interferon and immune responses (2 papers). Wanjun Lin collaborates with scholars based in Macao, China and United States. Wanjun Lin's co-authors include Wenzhe Ma, Jiajun Huang, Ying Xie, Senling Feng, Zhongwen Yuan, Yantao Li, Ze Long, Jingjing Du, Bowen Zheng and Xiaoming Huang and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and British Journal of Pharmacology.

In The Last Decade

Wanjun Lin

24 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanjun Lin Macao 9 233 84 62 52 52 28 375
Wengang Wang China 6 205 0.9× 81 1.0× 36 0.6× 45 0.9× 78 1.5× 7 363
Qian Zuo China 10 206 0.9× 78 0.9× 34 0.5× 33 0.6× 56 1.1× 14 352
Biyun Lin China 11 232 1.0× 66 0.8× 42 0.7× 29 0.6× 51 1.0× 21 426
Bin Wen China 11 240 1.0× 94 1.1× 57 0.9× 83 1.6× 38 0.7× 21 407
Yujuan Zhan China 12 274 1.2× 88 1.0× 29 0.5× 39 0.8× 38 0.7× 23 440
Liuning Li China 12 286 1.2× 125 1.5× 34 0.5× 74 1.4× 29 0.6× 23 427
Haojie Du China 8 184 0.8× 44 0.5× 48 0.8× 45 0.9× 40 0.8× 19 446
Jianyong Xiao China 15 370 1.6× 114 1.4× 39 0.6× 41 0.8× 46 0.9× 26 560
Rongli You China 7 278 1.2× 67 0.8× 73 1.2× 71 1.4× 37 0.7× 16 415
Yang Ke China 14 250 1.1× 126 1.5× 38 0.6× 72 1.4× 54 1.0× 34 617

Countries citing papers authored by Wanjun Lin

Since Specialization
Citations

This map shows the geographic impact of Wanjun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanjun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanjun Lin more than expected).

Fields of papers citing papers by Wanjun Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanjun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanjun Lin. The network helps show where Wanjun Lin may publish in the future.

Co-authorship network of co-authors of Wanjun Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Wanjun Lin. A scholar is included among the top collaborators of Wanjun Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanjun Lin. Wanjun Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Wanjun, et al.. (2025). Tanshinlactone triggers methuosis in breast cancer cells via NRF2 activation. Frontiers in Pharmacology. 15. 1534217–1534217.
2.
Ye, Qiuping, Lifang Liu, Wanjun Lin, et al.. (2025). The compensatory enrichment of sphingosine-1-phosphate on HDL in FSGS enhances the protective function of glomerular endothelial cells compared to MCD. Scientific Reports. 15(1). 1530–1530. 1 indexed citations
3.
4.
Wang, Zi, et al.. (2025). Low-dose statins restore innate immune response in breast cancer cells via suppression of mutant p53. Frontiers in Pharmacology. 16. 1492305–1492305.
5.
Chu, Tien‐Min Gabriel, Ai‐Jun Ma, Wanjun Lin, et al.. (2025). Discovery of Bi-magnolignan as a novel BRD4 inhibitor inducing apoptosis and DNA damage for cancer therapy. Biochemical Pharmacology. 235. 116843–116843.
6.
7.
Wang, Zi, et al.. (2024). Coptisine exerts anti‐tumour effects in triple‐negative breast cancer by targeting mitochondrial complex I. British Journal of Pharmacology. 181(21). 4262–4278. 4 indexed citations
8.
Zhang, Na, et al.. (2024). Yunnan baiyao exerts anti-glioma activity by inducing autophagy-dependent necroptosis. Journal of Ethnopharmacology. 335. 118658–118658. 4 indexed citations
9.
Yang, Yanchao, et al.. (2024). Species discrimination of Fritillaria Bulbus using PCR-CRISPR/Cas12a-based nucleic acid detection. Journal of Applied Research on Medicinal and Aromatic Plants. 43. 100589–100589. 1 indexed citations
10.
Wang, Zi, Wen‐Jian Lan, Jiachen Liu, et al.. (2024). Epiberberine inhibits bone metastatic breast cancer-induced osteolysis. Journal of Ethnopharmacology. 327. 118039–118039. 5 indexed citations
11.
Chen, Junhe, Zi Wang, Fuming Zhang, et al.. (2024). Notopterygium Incisum Extract Promotes Apoptosis by Preventing the Degradation of BIM in Colorectal Cancer. Current Medical Science. 44(4). 833–840. 1 indexed citations
12.
Xu, Jiaming, Lifang Liu, Qiuping Ye, et al.. (2024). Proteomic Analysis of Idiopathic Nephrotic Syndrome Triggered by Primary Podocytopathies in Adults: Regulatory Mechanisms and Diagnostic Implications. Journal of Proteome Research. 23(6). 2090–2099. 1 indexed citations
13.
Zhang, Na, Bowen Zheng, Xiaojun Yao, et al.. (2021). Identification and characterization of a novel mutant isocitrate dehydrogenase 1 inhibitor for glioma treatment. Biochemical and Biophysical Research Communications. 551. 38–45. 4 indexed citations
14.
Du, Jingjing, Xiaoming Huang, Na Zhang, et al.. (2021). Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells. Phytomedicine. 85. 153551–153551. 45 indexed citations
15.
Huang, Xiaoming, et al.. (2021). dsmCRISPR: Dual synthetic mismatches CRISPR/Cas12a-based detection of SARS-CoV-2 D614G mutation. Virus Research. 304. 198530–198530. 33 indexed citations
16.
Zhong, Fangfang, Xiaoming Huang, Na Zhang, et al.. (2020). High expression of HOXA5 is associated with poor prognosis in acute myeloid leukemia. Current Problems in Cancer. 45(3). 100673–100673. 5 indexed citations
17.
Lin, Wanjun, Jiajun Huang, Zhongwen Yuan, et al.. (2017). Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells. Scientific Reports. 7(1). 2022–2022. 60 indexed citations
18.
19.
Lin, Wanjun, Jiajun Huang, Zhongwen Yuan, et al.. (2016). Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha. Pharmacological Research. 111. 849–858. 29 indexed citations
20.
Li, Yantao, Jiajun Huang, Wanjun Lin, et al.. (2016). In Vitro Anticancer Activity of a Nonpolar Fraction from Gynostemma pentaphyllum (Thunb.) Makino. Evidence-based Complementary and Alternative Medicine. 2016(1). 6308649–6308649. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wengang Wang Breakdown of academic impact, for papers by Qian Zuo Breakdown of academic impact, for papers by Biyun Lin Breakdown of academic impact, for papers by Bin Wen Breakdown of academic impact, for papers by Yujuan Zhan Breakdown of academic impact, for papers by Liuning Li Breakdown of academic impact, for papers by Haojie Du Breakdown of academic impact, for papers by Jianyong Xiao Breakdown of academic impact, for papers by Rongli You Breakdown of academic impact, for papers by Yang Ke
Rankless by CCL
2026